A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells

Zhiguang Fu(State Key Laboratory of Cancer Biology), Zhi‐Nan Chen(National Medical Products Administration)

Oncotarget

January 23, 2016

10.18632/oncotarget.6990

Cited by 65

Related Papers

CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells

|Signal Transduction and Targeted Therapy|2020|1.2k

HAb18G/CD147 Functions in Invasion and Metastasis of Hepatocellular Carcinoma

|Molecular Cancer Research|2007|148

RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression

|Theranostics|2019|88

Receptor‐Interacting Protein Kinase 3 Deficiency Recruits Myeloid‐Derived Suppressor Cells to Hepatocellular Carcinoma Through the Chemokine (C‐X‐C Motif) Ligand 1–Chemokine (C‐X‐C Motif) Receptor 2 Axis

|Hepatology|2019|74

The interaction of HAb18G/CD147 with integrin α6β1 and its implications for the invasion potential of human hepatoma cells

|BMC Cancer|2009|69